This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Evaluation of Cost benefit Analysis using One-R Supervised Machine Learning Algorithm for Healthcare (preprint)
researchsquare; 2022.
Preprint
in English
| PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-2150222.v1
ABSTRACT
Pandemic was present for the entire world from 2019 to 2020. Due to this reason the workload for doctors and other healthcare professionals were increased. This workload will be eased by machine learning and the development of computer-aided analytical systems. The goal of the proposed methodology is towards the prevalence of COVID-19 to cost/benefit predictions on real-life dataset. Our proposed methodology is given for weka classification for the accuracy measurement ratios by applying 1R machine learning classifiers Considering the development of clustering with positive and negative occurrences ratios in terms of cost-benefit analysis's initial care projections. In this study 1R Supervised Machine Learning Algorithm have been applied to Covid 19 dataset provided by healthcare organization. The best classification accuracy is obtained from the algorithm of 1R with 75.54%. In this paper visualization Cost/Benefit Analysis and also analysed.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-RESEARCHSQUARE
Main subject:
COVID-19
Language:
English
Year:
2022
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS